NASDAQ:CLSD
Delisted

Clearside Biomedical Stock Insider Trading

etoro logo Buy CLSD
*Your capital is at risk
$0.410
+0 (+0%)
At Close: Mar 13, 2026

Clearside BioMedical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 8.65M and sold 95.53K CLSD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 8.65M shares
Sell 95.53K shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Sep 22, 2023
Buy
Common Stock
M-Exempt
Humphries William D.
Director
Director 22 727
Value: $9K
Sep 18, 2023
Buy
Employee Stock Option (right to buy)
A-Award
Deignan Charles A.
Chief Financial Officer
C-Suite Officer 100 000
Value: $84.9K
Sep 18, 2023
Buy
Employee Stock Option (right to buy)
A-Award
Lasezkay George M
CEO
CEO / President 200 000
Value: $169.8K
Sep 18, 2023
Buy
Employee Stock Option (right to buy)
A-Award
Lasezkay George M
CEO
CEO / President 200 000
Value: $169.8K
Sep 18, 2023
Buy
Employee Stock Option (right to buy)
A-Award
Deignan Charles A.
Chief Financial Officer
C-Suite Officer 100 000
Value: $84.9K
Sep 13, 2023
Buy
Common Stock
M-Exempt
Deignan Charles A.
Chief Financial Officer
C-Suite Officer 34 090
Value: $13.6K
Sep 13, 2023
Buy
Employee Stock Option (right to buy)
M-Exempt
Deignan Charles A.
Chief Financial Officer
C-Suite Officer 34 090
Value: $13.6K
Sep 13, 2023
Buy
Employee Stock Option (right to buy)
M-Exempt
Deignan Charles A.
Chief Financial Officer
C-Suite Officer 34 090
Value: $13.6K
Sep 13, 2023
Buy
Common Stock
M-Exempt
Deignan Charles A.
Chief Financial Officer
C-Suite Officer 34 090
Value: $13.6K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Thorp Clay
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Croarkin Richard
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Edwards Jeffrey L
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Humphries William D.
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Hutson Nancy J
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Shaffer Christy L
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Yerxa Benjamin R
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Yerxa Benjamin R
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Hutson Nancy J
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Humphries William D.
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Edwards Jeffrey L
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Croarkin Richard
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Shaffer Christy L
Director
Director 30 000
Value: $39.3K
Jun 22, 2023
Buy
Stock Option (right to buy)
A-Award
Thorp Clay
Director
Director 30 000
Value: $39.3K
Jan 20, 2023
Sell
Common Stock
S-Sale
Ciulla Thomas
Chief Medical Officer
Officer 13 700
Value: $20.1K
Jan 19, 2023
Sell
Common Stock
S-Sale
Lasezkay George M
CEO
CEO / President 20 030
Value: $29.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CLEARSIDE BIOMEDICAL, INC
Clearside BioMedical
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an i...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE